JPRN-jRCTs031180090已完成4 期
Beneficial Efficacy of Carperitide in Patients with Acute Decompensated Heart Failure - BEYOND registry
Ikari Yuji0 个研究点目标入组 162 人开始时间: 2019年1月21日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 162
研究概览
简要总结
This study suggested the safety and efficacy of low dose Carperitide in patients with acute heart failure. In addition, to treat effectively with using Carperitide, measurement of baseline ANP levels and focusing on the presence of HFpEF and AF would be necessary.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Hospitalized patients with acute heart failure and treated by administration of Carperitide.
排除标准
- •1 Under 20 years old
- •2 With ventricular assist device
- •3 Cardiogenic shock; treated by catecholamine
- •4 Dehydration
- •6 Allergy to Carperitide
- •7 Pregnancy, lactating woman
- •8 Acute myocardial infarction
研究者
相似试验
终止
4 期
The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal FailureHeart FailureRenal FailureNCT00613964Nara Medical University200
已完成
不适用
Beneficial Efficacy of Carperitide in Patients with Acute Decompensated Heart FailureJPRN-UMIN000028689Tokai University School of Medicine200
已完成
不适用
Effect of Low-Dose Carperitide in Patients With Acute Decompensated Heart Failure The Randomized Trial (Low-dose AdminiStration of CARperitide for Acute Heart Failure:LASCAR-AHF study)Acute Decompensated Heart FailureJPRN-UMIN000013819ational Cerebral and Cardiovascular Center, Division of Cardiovascular Medicine260
已完成
1 期
A Study of QT and QTc Intervals in Patients Administered Immediate Release PaliperidoneSchizoaffective DisorderSchizophreniaNCT00791349Johnson & Johnson Pharmaceutical Research & Development, L.L.C.141
招募中
不适用
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure PatientsInfection CardiacCardiac Implantable Electronic Device InfectionsHigh RiskHeart FailureNCT05103267Federico II University500